BWX Technologies (BWXT) earns a hold rating due to strong fundamentals but limited upside at current valuation. Naval business provides multi-year revenue visibility, supported by a $6.93 billion Government Operations backlog. Commercial Operations offers growth potential, with 39% organic revenue growth in Q1 2026 and margin expansion opportunities.
Artificial intelligence has an electricity problem, and nuclear is the answer investors keep circling back to.
BWXT raises its 2026 outlook as stronger operations support higher guidance, while a medical divestiture and PCG deal sharpen its nuclear focus.
BWX Technologies, Inc. (BWXT) Q2 2026 Earnings Call Transcript
BWX Technologies NYSE: BWXT reported second-quarter 2026 revenue growth of 18% and raised its full-year financial outlook, citing continued demand across nuclear national security and commercial power markets.
BWX Technologies (BWXT) came out with quarterly earnings of $1.07 per share, beating the Zacks Consensus Estimate of $1.01 per share. This compares to earnings of $1.02 per share a year ago.
BWXT heads into Q2 with nuclear, medical and defense demand supporting sales, while earnings are expected to edge lower.
XE and BWXT offer two distinct paths into the growing nuclear sector, from advanced reactor development to established government-backed nuclear operations.
BWX Technologies expands manufacturing investments to strengthen production capacity across defense, commercial nuclear and advanced reactor markets.
BWX (BWXT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
BWX Technologies expands advanced reactor capabilities through nuclear manufacturing, engineering and fuel technologies to support future deployment.
The U.S. nuclear sector advanced on two fronts in recent days. Advanced microreactors completed a key federal target while the existing commercial fleet signed a landmark agreement with a major retailer.